These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7016817)

  • 1. Amyloid P-component (protein AP) in localized amyloidosis as revealed by an immunocytochemical method.
    Westermark P; Shirahama T; Skinner M; Norén P; Cohen AS
    Histochemistry; 1981; 71(2):171-5. PubMed ID: 7016817
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis.
    Coria F; Castaño E; Prelli F; Larrondo-Lillo M; van Duinen S; Shelanski ML; Frangione B
    Lab Invest; 1988 Apr; 58(4):454-8. PubMed ID: 2965774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical demonstration of amyloid P component in cerebro-vascular amyloidosis.
    Rowe IF; Jensson O; Lewis PD; Candy J; Tennent GA; Pepys MB
    Neuropathol Appl Neurobiol; 1984; 10(1):53-61. PubMed ID: 6377111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid of the seminal vesicles. A distinctive and common localized form of senile amyloidosis.
    Pitkänen P; Westermark P; Cornwell GG; Murdoch W
    Am J Pathol; 1983 Jan; 110(1):64-9. PubMed ID: 6849372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of evidence for protein AA reactivity in amyloid deposits of lattice corneal dystrophy and amyloid corneal degeneration.
    Gorevic PD; Rodrigues MM; Krachmer JH; Green C; Fujihara S; Glenner GG
    Am J Ophthalmol; 1984 Aug; 98(2):216-24. PubMed ID: 6383050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cutaneous amyloidoses. Pathogenesis and therapy.
    Breathnach SM
    Arch Dermatol; 1985 Apr; 121(4):470-5. PubMed ID: 3883907
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunohistological characterisation of amyloid deposits in renal biopsy specimens.
    Fitzmaurice RJ; Bartley C; McClure J; Ackrill P
    J Clin Pathol; 1991 Mar; 44(3):200-4. PubMed ID: 2013620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies with radiolabelled serum amyloid P component provide evidence for turnover and regression of amyloid deposits in vivo.
    Hawkins PN
    Clin Sci (Lond); 1994 Sep; 87(3):289-95. PubMed ID: 7955904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The primary structure of human tissue amyloid P component from a patient with primary idiopathic amyloidosis.
    Prelli F; Pras M; Frangione B
    J Biol Chem; 1985 Oct; 260(24):12895-8. PubMed ID: 4055725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of different amyloids with immunological techniques.
    Chastonay P; Hurlimann J
    Pathol Res Pract; 1986 Dec; 181(6):657-63. PubMed ID: 3104892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Amyloid P component].
    Hamazaki H
    Seikagaku; 1990 Jan; 62(1):45-9. PubMed ID: 2138657
    [No Abstract]   [Full Text] [Related]  

  • 12. Hamster female protein, a sex-limited pentraxin, is a constituent of Syrian hamster amyloid.
    Coe JE; Ross MJ
    J Clin Invest; 1985 Jul; 76(1):66-74. PubMed ID: 4019787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical demonstration of amyloid P component in skin of normal subjects and patients with cutaneous amyloidosis.
    Breathnach SM; Bhogal B; Dyck RF; De Beer FC; Black MM; Pepys MB
    Br J Dermatol; 1981 Aug; 105(2):115-24. PubMed ID: 7025878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [AL- and AA-amyloidosis (the status of the problem)].
    Kochubeĭ LN; Vinogradova OM; Serov VV; Vasil'eva NA; Tomas NIu
    Klin Med (Mosk); 1988 Aug; 66(8):7-16. PubMed ID: 3057283
    [No Abstract]   [Full Text] [Related]  

  • 15. Ultrastructural localization of amyloid P component in primary localized cutaneous amyloidosis.
    Breathnach SM; Melrose SM; Bhogal B; de Beer FC; Black MM; Pepys MB
    Clin Exp Dermatol; 1983 Jul; 8(4):355-62. PubMed ID: 6354527
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibronectin and basement membrane components in renal amyloid deposits in patients with primary and secondary amyloidosis.
    Westermark GT; Norling B; Westermark P
    Clin Exp Immunol; 1991 Oct; 86(1):150-6. PubMed ID: 1914228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating serum amyloid P component is the precursor of amyloid P component in tissue amyloid deposits.
    Baltz ML; Caspi D; Evans DJ; Rowe IF; Hind CR; Pepys MB
    Clin Exp Immunol; 1986 Dec; 66(3):691-700. PubMed ID: 3568456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A primed state exists in vivo following histological regression of amyloidosis.
    Hawkins PN; Pepys MB
    Clin Exp Immunol; 1990 Aug; 81(2):325-8. PubMed ID: 2387095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of amyloid A (AA) protein and amyloid P component (AP) in deposits of systemic amyloidosis associated with renal adenocarcinoma.
    Hind CR; Tennent GA; Evans DJ; Pepys MB
    J Pathol; 1983 Feb; 139(2):159-66. PubMed ID: 6338184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical and immunochemical study of amyloid in liver affected by systemic Alambda amyloidosis with antibodies against three different regions of immunoglobulin lambda light chain.
    Kiyama M; Hoshii Y; Cui D; Kawano H; Kanda T; Ishihara T
    Pathol Int; 2007 Jun; 57(6):343-50. PubMed ID: 17539965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.